Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of ANG LIFESCIENCES INDIA. For more details, see the ANG LIFESCIENCES INDIA quarterly results and ANG LIFESCIENCES INDIA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.1 |
No. of shares | m | 13.06 |
1 Week | % | -8.8 |
1 Month | % | -0.1 |
1 Year | % | -31.6 |
52 week H/L | Rs | 91.0/44.5 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ANG LIFESCIENCES INDIA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 83 | 66 | 91 | 800 | 276 | |
Low | Rs | 29 | 28 | 27 | 87 | 72 | |
Sales per share (Unadj.) | Rs | 234.9 | 244.8 | 297.8 | 341.7 | 168.4 | |
Earnings per share (Unadj.) | Rs | 10.9 | 11.8 | 14.0 | 38.9 | -0.2 | |
Diluted earnings per share | Rs | 4.3 | 4.7 | 5.6 | 30.9 | -0.2 | |
Cash flow per share (Unadj.) | Rs | 13.1 | 14.1 | 18.3 | 44.5 | 7.0 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 1.00 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.79 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0.2 | 0 | |
Book value per share (Unadj.) | Rs | 55.5 | 66.7 | 79.8 | 80.8 | 66.0 | |
Adj. book value per share | Rs | 22.0 | 26.5 | 31.7 | 64.2 | 66.0 | |
Shares outstanding (eoy) | m | 5.18 | 5.18 | 5.18 | 10.37 | 13.06 | |
Price / Sales ratio | x | 0.2 | 0.2 | 0.2 | 1.3 | 1.0 | |
Avg P/E ratio | x | 5.1 | 4.0 | 4.2 | 11.4 | -867.2 | |
P/CF ratio (eoy) | x | 4.3 | 3.3 | 3.2 | 10.0 | 25.0 | |
Price / Book Value ratio | x | 1.0 | 0.7 | 0.7 | 5.5 | 2.6 | |
Dividend payout | % | 0 | 0 | 0 | 2.6 | 0 | |
Avg Mkt Cap | Rs m | 290 | 243 | 305 | 4,600 | 2,272 | |
Total wages/salary | Rs m | 64 | 72 | 143 | 213 | 240 |
ANG LIFESCIENCES INDIA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,217 | 1,268 | 1,543 | 3,543 | 2,199 | |
Other income | Rs m | 2 | 4 | 7 | 9 | 97 | |
Total revenues | Rs m | 1,219 | 1,273 | 1,550 | 3,552 | 2,296 | |
Gross profit | Rs m | 118 | 127 | 153 | 679 | 147 | |
Depreciation | Rs m | 11 | 12 | 22 | 59 | 94 | |
Interest | Rs m | 28 | 35 | 40 | 94 | 125 | |
Profit before tax | Rs m | 81 | 84 | 99 | 535 | 26 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 25 | 23 | 26 | 132 | 29 | |
Profit after tax | Rs m | 56 | 61 | 73 | 403 | -3 | |
Gross profit margin | % | 9.7 | 10.0 | 9.9 | 19.2 | 6.7 | |
Effective tax rate | % | 30.3 | 27.5 | 26.5 | 24.6 | 110.0 | |
Net profit margin | % | 4.6 | 4.8 | 4.7 | 11.4 | -0.1 |
ANG LIFESCIENCES INDIA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 600 | 727 | 1,119 | 1,928 | 1,852 | |
Current liabilities | Rs m | 424 | 509 | 919 | 1,663 | 1,623 | |
Net working cap to sales | % | 14.4 | 17.2 | 13.0 | 7.5 | 10.4 | |
Current ratio | x | 1.4 | 1.4 | 1.2 | 1.2 | 1.1 | |
Inventory Days | Days | 1 | 1 | 18 | 1 | 1 | |
Debtors Days | Days | 125,211,702 | 132,565,533 | 1,391 | 1,051 | 1,380 | |
Net fixed assets | Rs m | 209 | 214 | 299 | 939 | 887 | |
Share capital | Rs m | 52 | 52 | 52 | 104 | 131 | |
"Free" reserves | Rs m | 236 | 294 | 362 | 734 | 732 | |
Net worth | Rs m | 288 | 346 | 414 | 838 | 862 | |
Long term debt | Rs m | 63 | 53 | 59 | 216 | 205 | |
Total assets | Rs m | 809 | 941 | 1,418 | 2,867 | 2,756 | |
Interest coverage | x | 3.9 | 3.4 | 3.5 | 6.7 | 1.2 | |
Debt to equity ratio | x | 0.2 | 0.2 | 0.1 | 0.3 | 0.2 | |
Sales to assets ratio | x | 1.5 | 1.3 | 1.1 | 1.2 | 0.8 | |
Return on assets | % | 10.5 | 10.2 | 7.9 | 17.3 | 4.4 | |
Return on equity | % | 19.6 | 17.6 | 17.5 | 48.1 | -0.3 | |
Return on capital | % | 31.2 | 29.8 | 29.3 | 59.7 | 14.2 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 4 | 15 | 98 | 86 | 33 | |
Fx outflow | Rs m | 2 | 1 | 1 | 60 | 2 | |
Net fx | Rs m | 2 | 14 | 97 | 27 | 32 |
ANG LIFESCIENCES INDIA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 75 | 48 | -112 | 247 | 264 | |
From Investments | Rs m | -8 | -17 | -78 | -444 | -93 | |
From Financial Activity | Rs m | -38 | -39 | 188 | 199 | -171 | |
Net Cashflow | Rs m | 29 | -8 | -2 | 2 | -0 |
Share Holding
Shareholding as on Sep 2023
|
Company Information
|
CHM: Rajesh Gupta | COMP SEC: Renu Kaur | YEAR OF INC: 2006 | BSE CODE: 540694 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ANG LIFESCIENCES INDIA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.